COVID-19 Therapeutics I: Restoration of endothelial barrier function using adrecizumab to treat life-threatening organ failure (RESCUE) - initiation and overall coordination
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 03LW0002K
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$283,136.45Funder
Federal Ministry of Research, Technology and Space (BMFTR)Principal Investigator
N/A
Research Location
GermanyLead Research Institution
AdrenoMed AGResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
N/A